Hepatitis B virus (HBV) infection is a major public health problem worldwide.
Introduction
In the Mediterranean regions HBV seroprevalence ranged from intermediate (≥2%) to high prevalence (≥7%). (Institute of medicine, 2010). In Iraq, a national survey was conducted based on community-basis [1] , which indicates that, national prevalence rate of HBsAg was 1.6% correlated positively with age, while the prevalence rate of anti-HBs, anti-HBc antibodies were 17% and 9.7% respectively [1] .These findings indicates the need for seroepidemiological and molecular epidemiological studies to be performed in different Iraqi Governorates to build a data that are essential for prevention and control of HBV infection and reduction of the burden of the disease on the society.
HBV genome nucleotide diversity causes a difference in response to antivirus treatment .Hepatitis B virus is classified to 8 genotypes (A to H) based on the difference in more than 8% of complete genome sequence [2] .These genotypes have different geographical distribution. Genotypes A and D are more common in Europe, Russia, India, and North of Asia; genotypes B and C are more common in East Asia and Australia; and genotypes H, F, and G are more distributed in Central and South America. [2] . Global distribution of HBV genotypes/sub genotypes were reported in literature [2] . Ten genotypes, from genotype A to J of HBV were identified [3, 4, and 5] . The genotypes have different geographical distribution. Genotypes A and D are more common in Europe, Russia, India, and North of Asia; genotypes B and C are more common in East Asia and Australia; and genotypes H, F, and G are more distributed in Central and South America. During the past decade, PCR based techniques have extensively been used in molecular diagnosis of disease [5] . HBV genotype is recognized as an important gene type since it is associated to treatment response, disease prognosis and development of liver cirrhosis and hepatocellular carcinoma [6, 7, 8, 9, and 10] . In Iraq, studies reported that genotype D is the predominant genotype in HBV acute and chronic infections [12] and another study reported that genotype D is predominant among blood donors [11] . In Arab countries, the predominant genotype was D [13] [14] [15] [16] [17] [18] [19] [20] [21] .
Therefore, aim of this study was to determine hepatitis B virus genotypes in chronic hepatitis B virus infection in Samara City.
Materials and Methods

Study Population
The study population are individuals with HBV chronic infection recruited from Samarra General Hospital and blood bank in Samarra city, who diagnosed as cases of hepatitis B and attend to the hospital for monitoring and follow-up. The target number recruited for chronic cases are 100 subjects from , but 4 of them were defaulted. Of the total 96 enrolled in the study, 45 (47%) are female, recruited between 2012-2013 from total number tested 4673 .
Sample collection
From each patients introduced in this study, 5ml of blood was drawn by veinpuncture using disposable syringes. The collected blood was placed in disposable plastic tubes. The blood specimens were left at room temperature (20-25 C) for clotting. The sera were separated by centrifugation for 5 min., after that divided into aliquots 200µl (8 tubes for each sample) and stored at -20°C until use [22, 23] . Each part of sera was used once to avoid repeated thawing and freezing. All materials (i.e. reagents and sera) were allowed to stand at room temperature before use. Before testing for HBV biomarkers, all samples screened for HIV. All the serum samples were tested for HBsAg, HBsAb, HBeAg, HBeAb, HBcIgM, and HBcIgG by commercially-available (ELISA) kits. The results read by a Microwell reader and compared in a parallel manner with controls; optical density read at 450 nm on an ELISA reader.
Hepatitis B Virus Genotyping:
DNA was isolated from serum samples using the Qiagen QiAmp Mini Kit (Valencia, CA). The quality of isolated DNA was checked by agarose gel electrophoresis and the concentration was measured using a NanoDrop spectrophotometer (Thermo Scientific). The PCR reaction was performed in a total volume of 20 µl using AccuPower PCR premix Kit purchased from BIONEER Company (Korea). Primers used in this study were those used by Chen et al., [24] 2007 shown in table 1. The PCR cycling was carried out on Eppendorf Master Cycler (Germany). Cycling condition was performed as follows: 95 °C for 5 minutes as initial Denaturation, 94 °C for 1 minute, 59 °C for 1 minute, and 72 °C for 1 minute for 35 cycles, and 72 °C for 5 minutes as final extension. Genotypes were determined after electrophoresis on 2% agarose gels containing ethidium bromide and visualized directly under ultraviolet illumination using gel documentation system (figure 1), a 100 bp ladder was used to score the band sizes.
Analysis of Data:
Collected data are compiled in Microsoft Excel spreadsheet. The proportion and the mean value were computed in appropriate situations. To find out any association between categorical data, Chi square test is to be employed using the SPSS (Version 16). The study finding data are presented as frequency and/or mean ± SD. 
Results:
The frequencies of hepatitis B genotyping are shown in " Fig. 1 " and Table 2 . The difference in mean serum value (IL-17) between negative cases and with D genotype was marginally significant, but it was significant between D genotype and combined genotypes (P=0.0018-0.0001). All cases with negative viral load demonstrated positive HBeAb i.e 56.2% of HBeAb positive cases which is 9.4% of total tested samples (9/96). No positive cases for HBeAb in C genotype, while in D genotype 7 cases were positive i.e 43.8% of the total HBeAb positive cases which is 7.3% (7/96) of total tested samples. All the 3 combination of genotypes cases were negative for HBeAb. However, the differences for HBeAb positivity between negative cases and different genotypes cases were highly significant (X 2 =49.95, P=0.000), Table 4 . The frequency distribution of HBsAb positivity (Table.8 ) was with significant difference between the genotypes (X2=31.33, P=0.000). For C genotype, 2 cases (66.7%) with negative HBsAb and one case (33.3%) with positive HBsAb, with significant difference (X2=31, P=0.000). All cases of D genotype were negative for HBsAb with significant value (X2=5.46, P=0.019). The 3 genotype combinations were negative for HBsAb. The frequency distribution of HBcIgG positivity (Table.10 
Disccussion:
At least eight different genotypes (A-H) have been identified [2] . The present study indicated that D genotype was the predominant (93.1%, 81/87) genotype. In Mosul, Iraq, Shafiq [12] [2013] reported that genotype D is the predominant genotype in HBV acute and chronic infections. In addition, another study found that D genotype is the predominant among Mosul blood donors [11] .In Arab countries the predominant genotype was D in Saudi Arabia [13] , United Arab Emirates [14] , Yemen [15] , Lebanon [16] , Jordan [17] , Egypt [25] , Libya [18] Mauritania [19] , Morocco [20] , and Syria [21] .
Although, D is the most common genotype among Arab states, in Sudan, D and E genotypes reported as predominant [26] . The present study reports genotype C in 3.45% and mixed genotype of C& F, A & D and B & D combinations in 1.15% of our study population for first time. Genotype E was not detected in our study population. In regard to our knowledge, this is for the first time in reporting genotypes A, B, C, and F in Arab countries.
In Iran, D genotype was the only detected genotype in different clinical forms of hepatitis B virus infections [27, 28, and 29] . In Pakistan, genotype A, B and C was detected as the predominant, while D is rare [30] . In Turkey, D genotype is the dominant cause of HBV infections [31] .
HBV genotypes have distinctive geographical distribution [2] .
Genotype A is more prevalent in North-West Europe, North America, Central Africa and India and in some regions of South America.
Genotype B and C are present in Asia.
Genotype D is endemic in Mediterranean region, Middle East, Eastern Europe and South Asia, particularly in India, although it can also be found all over the world.
Genotype E is found in West Africa.
Genotype F is present in South and Central America.
Genotype G reported in France, Central America, Germany, Mexico and United States.
Genotype H seems restricted to northern part of Latin America, including Central America and Mexico [32] [33] [34] .
In a recent study [35] that determine HBV genotype among immigrants to Italy (East Europe, sub-Saharan Africa, East -Asia, Central Africa, and Middle East], indicated that genotype E forms 45.13%, while 18.1% genotype D, 15.3% genotype B, 13.2% genotype C, 4.9% genotype A and 3.5% mixed genotypes (A-D). They found that genotype A was associated to Somali, B and C to Chinese, D to Pakistani, E to Eritrean, A-D mixed genotypes to Pakistani.
In this study demonstrate the genotyping D is predominate in samarra city and distinctive geographical in Asia, but reported new genotyping firstly that indicated to occur mutations in gene of Hepatitis B virus causes appearance new genotypes not reported with another study.
HBV genotyping is important since clinical manifestation of persistent hepatitis B virus infection is associated with distinctive genotype [33] .Response to interferon therapy was better in genotype A and B than in genotype C and D [36] .In Europe, most patients with genotype A have chronic hepatitis, whereas genotype D has acute infection [37] .However, in India, genotype D was found to be associated with more severe disease and hepatocellular carcinoma in young patients with genotype A [38] .
Reported studies found an association between HBV genotype and development of hepatocellular carcinoma, >50% of hepatocellular carcinoma patients were infected with genotype B in a Taiwan study [39] .In addition, hepatocellular carcinoma in younger patients in Taiwan predominantly infected with hepatitis B virus genotype B compared to genotype C [39] .In contrast, in Japan, genotype B is rarely correlated with hepatocellular carcinoma development and only in older age [40] . The disparity concerning the association of genotype B and development of hepatocellular carcinoma between Japan and Taiwan may be due differences in sub-genotype as it is B1 in Japan and B1 in Taiwan [41] . This disparity indicated the importance of sub-genotyping in areas with high predominance of B genotype.
The reported study indicated that >95% of hepatitis patients in Italy was due to genotype D [34] . But immigrants modify the normal geographical distribution of hepatitis B virus genotype, with the introduction of non D genotype [35] . Thus population movement within the same country and migration between countries must be taken into consideration and follow up studies for genotyping at time interval is essential global issue.
The present study indicated an association between chronic HBV infection severity and D genotype depending on biomarkers because the patients refused to undergo biopsy. The findings in this study confirm that ,such association include: firstly, IL-17 mean serum level was significantly higher in hepatitis B cases with genotype D as compared to those with negative viral load that mean found danger to heath live because IL-17 play role in cellular immunity to guard liver from injury; secondly, HBe antibody positivity significantly higher in negative viral load compared to chronic cases with D genotype; thirdly, in cases with genotype D, HBsAg positivity forms 83.5% of total HBsAg positive cases; fourthly, no HBs antibody positivity in cases with D genotype to refer the recover patients in non occur or difficult in these genotypes ; fifthly, high rate of HBcIgM (75%) and HBeAg positivity in cases with D genotype indicating that the majority of the cases are active chronic hepatitis B infections.
In the present study, hepatitis B genotype C frequency was with no significant difference between the age groups. Two cases (2.1%) with C genotype in the 15-45 years age group, while one case (1%) in less than 14 years age group. The frequency distribution of D genotype was with significant differences between the age groups. Of the total 81 cases with D genotype, 65 cases, which form 67.7% of total, thirteen cases (13.5% of total) in the age group of >45 years, while 3 cases (3.1% of total) in the age of ≤14 years. Genotype combination of C & F , B & D were with 1% frequency in the 15-45 years age group, while A & D genotype combination form 1% in >45 years age group. The genotype frequency distribution according to age groups not demonstrated a significant differences between the age groups.
This study indicated that gender did not influence HBV genotype in our study population. This is consistent with others who reported predominance of D genotype in the studies performed in Arab countries that included females only [13] [14] [15] [16] [17] [18] [19] [20] [21] .
Hepatitis B genotype frequency distribution was not demonstrated a significant differences in relation to gender. However, C genotype found in 2 (2.1% of total) female cases and 1 male cases (1% of total), to form 4.4% and 2% within the gender respectively. In addition, 66.7% cases of C genotype were in female and 33.3% in male, but without significant difference. Finally this study contributed that HBV represent a health problem in Samara community and they have great socioeconomic impact that might affect future generations and influence the infrastructure of Samara community, which need an urgent actions from healthcare providers. In addition, results of tome trend analysis suggest that, contrary to expectations, there appear an increase in prevalence of both HBV and HCV in general population. Furthermore, HBV A, B, C, and F genotypes are reported for the first time in Iraq and may be Arab countries and Mediterranean Region.
There are some limitations for this study which include: (a) Lack of some information regarding subjects included in retrospective study which affect the range of data analysis; (b) The patients enrolled in prospective part of the study refused to be undergo liver biopsy, therefore for the evaluation of the liver disease degree we considered the noninvasive markers for disease severity; (c) Kits that needed to determine certain markers are costly and this high cost limited the number of sample tested for each biomarkers; (d) Some of the data obtained were based on patients or parents in children, self-reporting of risk factors, which is subject to social desirability bias. However, because of large number of individuals data included in the retrospective part of the study, the study population is a good representative of the entire Samara district community, which significantly reduce such bias; (e) Social and sexual behaviors are important determinants in HBV and HCV transmission and this was not assessed in this study because the surveillance data in Samara General Hospital is not stick to the standards and (f) The study not determine the difference in seroprevalence of the disease between urban and rural areas.
